← All stocks

PALISADE BIO, INC.

PALI Net buying
CIK 0001357459 #3389 in the set updated 18 Sep 2026
Bought (12 mo)
$267.94K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$420.18K
$0.00 on a plan · $303.34K straight out of an exercise
Sold at will
$116.83K
3 of 4 sales
Net
−$152.24K
+$151.10K against sales at will

By person

7 insiders · 12 transactions
0.7×

J.D. Finley holds only 0.7 times base salary in stock. $425.90K of shares against $575.00K in salary for 2025.

Salary from the company's own proxy. The shares are what J.D. Finley last reported holding, valued at $1.96, the price Common Stock was last bought or sold at on the open market here, on 9 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Finley John David
CEO, CFO
$310.16K (2) scheduled
−$310.16K
217,739
$425.90K
+999.7%
Baltera Robert Jr.
Director
$250.18K (6)
+$250.18K
461,904
$903.48K
Jones Mitchell Lawrence
Chief Medical Officer
$110.02K (2)
−$110.02K
94,009
$183.88K
+979.2%
Williams Donald Allen
Director
$17.76K (2)
+$17.76K
1,570,294
$3.07M
+461,751%
Wei Binxian
Director
613,355
$1.20M
+131,239%
Chuang Emil
Director
612,500
$1.20M
Zwick Jordan Michael
Director
336,904
$658.98K

No percentages here. This company's share count has moved by a factor of 131.1 over the window, from 1,329,516 to 174,270,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Finley John David
7 Jul 2026
CEO, CFO
Sold after exercise
146,798
$2.07
$303.34K

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 4,122,974
History held since 26 Sep 2016